30384 Federal Register / Vol. 72, No. 104 / Thursday, May 31, 2007 / Notices 

scientific reviews of applications for 

AHRQ support. Individual members of 

the Panel do not attend regularlyscheduled meetings and do not serve for 

fixed terms or a long period of time. 

Rather, they are asked to participate in 

particular review meetings which 

require their type of expertise. 

Substantial segments of the upcoming 

SEP meeting listed below will be closed 

to the public in accordance with the 

Federal Advisory Committee Act, 

section 10(d) of 5 U.S.C., Appendix 2 

and 5 U.S.C. 552b(c)(6). Grant 

applications for ‘‘Ambulatory Safety and 

Quality Program: Improving Quality 

through Clinician Use of Health IT 

(R18),’’ are to be reviewed and 

discussed at this meeting. These 

discussions are likely to reveal personal 

information concerning individuals 

associated with the applications. This 

information is exempt from mandatory 

disclosure under the above-cited 

statutes. 

SEP Meeting on: Ambulatory Safety and 

Quality Program: Improving Quality through 

Clinician Use of Health IT (R18). 

Date: July 10–12, 2007 (Open on July 11 

from 8 a.m. to 8:15 a.m. and closed for the 

remainder of the meeting). 

Place: Gaithersburg Marriott 

Washingtonian Center, 9751 Washingtonian 

Boulevard, Gaithersburg, Maryland 20878. 

Contact Person: Anyone wishing to obtain 

a roster of members, agenda or minutes of the 

non-confidential portions of this meeting 

should contact Mrs. Bonnie Campbell, 

Committee Management Officer, Office of 

Extramural Research, Education and Priority 

Populations, AHRQ, 540 Gaither Road, Room 

2038, Rockville, Maryland 20850, Telephone 

(301) 427–1554. 

Agenda items for this meeting are subject 

to change as priority dictate. 

Dated: May 22, 2007. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 07–2688 Filed 5–30–07; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality Contract Review Meeting 

In accordance with section 10(a) of 

the Federal Advisory Committee Act as 

amended (5 U.S.C., Appendix 2), 

announcement is made of an Agency for 

Healthcare Research and Quality 

(AHRQ) Technical Review Committee 

(TRC) meeting. This TRC’s charge is to 

provide, on behalf of AHRQ, review of 

contract proposals and 

recommendations to the Director, 

AHRQ, regarding the technical merit of 

proposals submitted in response to a 

Request for Proposals (RFPs) regarding 

‘‘Evidence-based Practice Centers’’, 

issued on March 8, 2007. 

The upcoming TRC meeting will be 

closed to the public in accordance with 

the Federal Advisory Committee Act 

(FACA), section 10(d) of 5 U.S.C., 

Appendix 2, implementing regulations, 

and procurement regulations, 41 CFR 

101–6.1023 and 48 CFR section 

315.604(d). The discussions at this 

meeting of contract proposals submitted 

in response to the above-referenced RFP 

are likely to reveal proprietary and 

personal information concerning 

individuals associated with the 

proposals. Such information is exempt 

from disclosure under the above-cited 

FACA provision that protects the free 

exchange of candid views, and under 

the procurement rules that prevent 

undue interference with Committee and 

Department operations. 

Name of TRC: The Agency for HealthCare 

Research and Quality, ‘‘Evidence-based 

Practice Centers’’. 

Date: June 11–12, 2007. 

Place: Agency for HealthCare Research and 

Quality, 540 Gaither Road, Conference 

Center, Rockville, Maryland 20850. 

Contact Person: Anyone wishing to obtain 

information regarding this meeting should 

contact Beth Collins-Sharp, Center for 

Outcomes and Evidence, 540 Gaither Road, 

Rockville, Maryland 20850, (301) 427–1503. 

Dated: May 22, 2007. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 07–2681 Filed 5–25–07; 10:42 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel: Occupational Health 

and Safety Research Member Conflict, 

Program Announcement (PA) 04–038 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces a meeting of the 

aforementioned Special Emphasis 

Panel. 

Time and Date: 1 p.m.–4 p.m., July 12, 

2007 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters To Be Discussed: The meeting will 

include the review, discussion, and 

evaluation of research grant applications in 

response to ‘‘Occupational Health and Safety 

Research Member Conflict,’’ PA 04–038. 

Contact Person for More Information: 

George Bockosh, Scientific Review 

Administrator, 625 Cochrans Mill Road, 

Mailstop P–05, Pittsburgh, PA 15222, 

telephone (412) 386–6465. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: May 24, 2007. 

Elaine L. Baker, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. E7–10421 Filed 5–30–07; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel: Applied Research in 

Antimicrobial Resistance: Studies of 

Susceptibility Testing on Gramnegative Multidrug Resistant 

Organisms, Funding Opportunity 

Announcement (FOA) CI07–003 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces a meeting of the 

aforementioned Special Emphasis 

Panel. 

Time and Date: 12 p.m.–4 p.m., June 28, 

2007 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters to be Discussed: The meeting will 

include the review, discussion, and 

evaluation of research grant applications in 

response to FOA CI07–003, ‘‘Applied 

Research in Antimicrobial Resistance: 

Studies of Susceptibility Testing on Gramnegative Multidrug Resistant Organisms.’’

Contact Person for More Information: 

Trudy Messmer, PhD, Scientific Review 

Administrator, 1600 Clifton Road, Mailstop 

C–19, Atlanta, GA 30333, telephone (404) 

639–2176. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 


sroberts on PROD1PC70 with NOTICES